Purchases and Sales Made in Q2 2022 in Mirati Therapeutics, Inc. (MRTX)
This table provides information about the institutional ownership of Mirati Therapeutics, Inc. (MRTX) during Q2 2022. The information is specifically focused on institutions that hold shares of Mirati Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 29, 2022
Q2 2022
|
Sg Americas Securities, LLC
|
SELL
|
- |
-46.7K- 81.41% |
$1.83M - $4.14M
|
10.7K
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Eagle Health Investments LP
Greenwich, CT |
SELL
|
- |
-52KClosed |
$2.04M - $4.61M
|
0
$0
|
|
|
Aug 16, 2022
Q2 2022
|
Clough Capital Partners L P
Boston, MA |
SELL
|
- |
-52.9KClosed |
$2.07M - $4.69M
|
0
$0
|
|
|
Sep 21, 2023
Q2 2022
|
Jefferies Group LLC
New York, NY |
SELL
|
- |
-65.5K- 86.97% |
$2.57M - $5.81M
|
9.82K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Jefferies Group LLC
New York, NY |
SELL
|
- |
-66.5K- 86.32% |
$2.6M - $5.9M
|
10.5K
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-70.2K- 24.42% |
$2.75M - $6.23M
|
217K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-99.6K- 44.4% |
$3.9M - $8.83M
|
125K
$0
|
|
|
Aug 01, 2022
Q2 2022
|
Victory Capital Management Inc
|
SELL
|
- |
-108KClosed |
$4.24M - $9.59M
|
0
$0
|
|
|
Aug 05, 2022
Q2 2022
|
Bank Of Nova Scotia
|
SELL
|
- |
-110KClosed |
$4.31M - $9.76M
|
0
$0
|
|
|
Aug 09, 2022
Q2 2022
|
Pictet Asset Management Sa
Geneva 73, V8 |
SELL
|
- |
-140K- 36.97% |
$5.49M - $12.4M
|
239K
$0
|
|
|
Aug 16, 2022
Q2 2022
|
International Biotechnology Trust PLC
London, X0 |
SELL
|
- |
-179K- 95.16% |
$7.02M - $15.9M
|
9.13K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-210K- 22.29% |
$8.22M - $18.6M
|
732K
$0
|
|
|
Aug 11, 2022
Q2 2022
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-250K- 18.52% |
$9.79M - $22.2M
|
1.1M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-270KClosed |
$10.6M - $24M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-341K- 75.1% |
$13.3M - $30.2M
|
113K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-350KClosed |
$13.7M - $31M
|
0
$0
|
|
|
Aug 12, 2022
Q2 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-387K- 13.84% |
$15.2M - $34.4M
|
2.41M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-501KClosed |
$19.6M - $44.4M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-540K- 33.12% |
$21.2M - $47.9M
|
1.09M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Camber Capital Management LP
Boston, MA |
SELL
|
- |
-550K- 45.83% |
$21.5M - $48.8M
|
650K
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-593K- 36.05% |
$23.2M - $52.6M
|
1.05M
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Ra Capital Management, L.P.
Boston, MA |
SELL
|
- |
-734KClosed |
$28.8M - $65.1M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-1.39MClosed |
$54.5M - $124M
|
0
$0
|